Investigating Pathogenic Mechanisms And Therapeutic Targets For mtDNA Mutations in Cambridge

Investigating Pathogenic Mechanisms And Therapeutic Targets For mtDNA Mutations in Cambridge

Cambridge Full-Time 25650 - 31350 £ / year (est.) On-site
N

At a Glance

  • Tasks: Investigate mitochondrial DNA mutations and their impact on cell health using innovative models.
  • Company: Join the MRC Centre of Research Excellence in Mitochondrial Genome Therapeutics.
  • Benefits: Gain hands-on research experience and contribute to groundbreaking therapeutic developments.
  • Other info: Collaborative environment with opportunities for career advancement in cutting-edge science.
  • Why this job: Make a real difference in understanding and treating inherited mitochondrial diseases.
  • Qualifications: Background in biology or related fields; passion for research and innovation.

The predicted salary is between 25650 - 31350 £ per year.

Mutations in mitochondrial DNA (mtDNA) are the most common cause of inherited mitochondrial disease and are increasingly implicated in common age-related conditions including neurodegeneration. The pathogenic mechanisms of mtDNA mutations are poorly understood partly due to the striking phenotypic heterogeneity and complications of dynamic mutation heteroplasmy, rendering these conditions very difficult to treat.

This project forms an integral part of the recently established MRC Centre of Research Excellence in Mitochondrial Genome Therapeutics (MRC CoRE-MitoGT) and is supported by one of several studentships established in collaboration with the Lily Foundation and LHON Collective. CoRE-MitoGT is an international consortium that ultimately aims to understand how mtDNA mutations cause disease and develop therapies targeting their root causes.

The student will join the Whitworth lab, one of the core laboratories within CoRE-MitoGT, based at the Cambridge Institute for Medical Research, to investigate how different cell types respond to pathogenic mtDNA mutations and identify the mechanisms that determine whether cells degenerate or tolerate a comparable mutation load. In parallel, the project aims to establish whether mitochondrial quality control pathways can be manipulated to reduce mutant mtDNA levels and restore mitochondrial function in vivo, while systematically identifying nuclear-encoded regulators that could provide new therapeutic targets.

The work will centre on unique, new Drosophila models of the primary mitochondrial disease, MELAS, generated in the laboratory by mtDNA base editor-mediated mutagenesis. These models allow heteroplasmy to be measured and manipulated in a genetically tractable, short-lived animal and its consequences followed throughout development and ageing. They will be studied alongside iPSC-derived human neurons carrying pathogenic mtDNA mutations at defined heteroplasmy levels, allowing mechanisms identified in the fly to be tested for conservation in human cells.

The project will combine hypothesis-driven and unbiased approaches to:

  • Define cell-type-specific disease responses: Deep phenotyping of heteroplasmic MELAS models across development and ageing, including mitochondrial and other molecular functions, and impacts on behaviour and lifespan, to establish when and where dysfunction first appears and how it relates to mutation load.
  • Assess and manipulate mitochondrial quality control pathways: Determine whether QC pathways such as mitophagy and mtDNA copy number regulators are activated by mtDNA mutations; Target established and novel regulators of mitophagy and determine their effects on heteroplasmy, mitochondrial function and organismal vitality.
  • Identify new regulators: Perform forward-genetic screens in heteroplasmic MELAS fly models to identify nuclear-encoded regulators of mtDNA heteroplasmy and copy number.
  • Test therapeutic candidates across systems: Progress the strongest candidates into human neuronal models and, in collaboration with partner groups, mammalian systems, prioritising mechanisms with therapeutic potential, druggability and translational relevance.

Findings from these approaches will be integrated with mammalian and single-cell datasets generated by collaborating groups, positioning the mechanisms identified here within a broader multiscale understanding of mtDNA disease. The overall goal is to establish both why some cell types are selectively vulnerable to mtDNA mutations and whether mitochondrial quality control can be harnessed to prevent or reverse this vulnerability. In doing so, the project will test the potential of enhancing mitochondrial quality control as a mutation-agnostic therapeutic strategy.

Investigating Pathogenic Mechanisms And Therapeutic Targets For mtDNA Mutations in Cambridge employer: Nuclear Inst

Cavendish Nuclear is an exceptional employer, offering a dynamic work environment where you can shape the future of the UK's nuclear industry while enjoying flexible working arrangements across various locations. With a strong focus on employee development, generous benefits including matched pension contributions and health support, and a commitment to inclusivity, Cavendish fosters a culture that values your contributions and promotes a healthy work-life balance.

N

Contact Details:

Nuclear Inst Recruitment Team

StudySmarter Expert Advice🤫

We think this is how you could land Investigating Pathogenic Mechanisms And Therapeutic Targets For mtDNA Mutations in Cambridge

✨Get Involved in Local Research Communities

Tap into local biotechnology meetups and research forums. These are great places to mingle with industry professionals, share your passion, and even discover unadvertised job openings. It's all about getting your face known in the field!

✨Leverage University Alumni Networks

If you're a recent grad, don’t underestimate the power of your university’s alumni network! Reach out to alumni working in biotechnology to gather tips about job openings at companies like Nuclear Inst. You'd be surprised how willing people are to help out a fellow grad!

✨Show Off Your Projects

Curate a portfolio showcasing any research projects or internships you've completed in biotechnology. This tangible evidence of your skills can really impress employers when you chat with them at networking events or interviews. It's about making that killer first impression!

✨Stay Up-to-Date with Industry Trends

Biotech is a fast-paced field, so keeping yourself updated with the latest advancements is crucial. Attend industry conferences, webinars, or workshops to broaden your knowledge and meet potential employers. Plus, it’ll give you fantastic talking points for your interviews at places like Nuclear Inst!

We think you need these skills to ace Investigating Pathogenic Mechanisms And Therapeutic Targets For mtDNA Mutations in Cambridge

Communication Skills
Problem-Solving Skills
Teamwork
Organizational Skills
Compassion
Flexibility
Adaptability

Some tips for your application 🫡

Show Off Your Lab Skills:In the biotechnology field, it's super important to highlight your lab experience in your CV. Be sure to mention specific techniques or instruments you've mastered (think PCR, gel electrophoresis, etc.) and any relevant projects you've worked on. This will show Nuclear Inst that you have the hands-on skills they need.

Tailor Your Technical Skills:Make sure to emphasise your technical skills, especially those relevant to the biotechnology sector. Include any software tools or programming languages you've used, like R or Python for data analysis, which could be key for this role at Nuclear Inst.

Craft a Compelling Cover Letter:Since this is a full-time role, your cover letter should reflect not only your passion for biotechnology but also your long-term career ambitions. Share why you're excited about the work that Nuclear Inst does and how you envision contributing to their goals. This shows that you’re not just looking for any job, but you're genuinely invested in this opportunity.

Include Your Papers and Projects:If you've published any papers or contributed to significant projects, mention them! These documents can boost your application and provide tangible evidence of your expertise in the biotechnology field. Don’t forget to link to any relevant publications or project summaries—this can set you apart from other candidates.

How to prepare for a job interview at Nuclear Inst

✨Brush Up on Lab Techniques

Since you're eyeing a full-time gig in biotechnology, make sure you're well-versed in the lab techniques relevant to the role. Be ready to talk about PCR, CRISPR, or any specific methods mentioned in the job description at Nuclear Inst. You might even be asked to demonstrate your understanding of these processes.

✨Know Your Bioinformatics Tools

Get comfortable with bioinformatics tools that are commonly used in the industry, like BLAST or Bioconductor. These are key in biotechnology, and having hands-on experience or at least familiarity can set you apart. Prepare to discuss any relevant projects you've worked on, especially if they involved data analysis or genomic research.

✨Show Your Teamwork Skills

Biotech often involves collaboration across multiple disciplines. Be ready to share stories that highlight your teamwork and communication skills, especially in research projects. Think about working with different teams at university or any internships – this is where you can show how well you fit into Nuclear Inst's culture.

✨Research Recent Biotech Innovations

Stay updated on the latest trends and breakthroughs in biotechnology. Knowing what's happening in the field can help you engage in more meaningful discussions during your interview. Bring up recent articles or advancements that excite you, especially those related to the work being done at Nuclear Inst. This shows your passion for the industry!